Next earnings date: 11 Aug 2025

Medicine Man Technologies, Inc. – OTC:SHWZ
Medicine Man Technologies stock price today
Medicine Man Technologies stock price monthly change
Medicine Man Technologies stock price quarterly change
Medicine Man Technologies stock price yearly change
Medicine Man Technologies key metrics
Market Cap | 74.42M |
Enterprise value | 165.86M |
P/E | -2.24 |
EV/Sales | 1.04 |
EV/EBITDA | 5.56 |
Price/Sales | 0.35 |
Price/Book | 0.42 |
PEG ratio | N/A |
EPS | -0.73 |
Revenue | 174.04M |
EBITDA | 16.05M |
Income | -52.34M |
Revenue Q/Q | 4.00% |
Revenue Y/Y | 3.84% |
Profit margin | -16.48% |
Oper. margin | 8.07% |
Gross margin | 53.35% |
EBIT margin | 8.07% |
EBITDA margin | 9.22% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedicine Man Technologies stock price history
Medicine Man Technologies stock forecast
Medicine Man Technologies financial statements
Jun 2023 | 42.37M | -6.60M | -15.59% |
---|---|---|---|
Sep 2023 | 46.74M | -322.46K | -0.69% |
Dec 2023 | 43.32M | -29.36M | -67.78% |
Mar 2024 | 41.60M | -16.05M | -38.59% |
2025 | 192M | -30.33M | -15.8% |
---|
Analysts Price target
Financials & Ratios estimates
2024-08-13 | -0.19 | -0.2 |
---|---|---|
2024-11-11 | -0.2 | -0.2 |
Jun 2023 | 368958912 | 220.90M | 59.87% |
---|---|---|---|
Sep 2023 | 370590687 | 224.80M | 60.66% |
Dec 2023 | 358144332 | 238.85M | 66.69% |
Mar 2024 | 346606776 | 242.72M | 70.03% |
Jun 2023 | 2.68M | -17.62M | -352.88K |
---|---|---|---|
Sep 2023 | 6.94M | -4.74M | -2.45M |
Dec 2023 | 3.45M | -1.16M | -2.65M |
Mar 2024 | -3.70M | -1.53M | -864.93K |
Medicine Man Technologies alternative data
Aug 2023 | 651 |
---|---|
Sep 2023 | 651 |
Oct 2023 | 651 |
Nov 2023 | 651 |
Dec 2023 | 651 |
Jan 2024 | 651 |
Feb 2024 | 651 |
Mar 2024 | 651 |
Apr 2024 | 651 |
May 2024 | 729 |
Jun 2024 | 729 |
Jul 2024 | 729 |
Medicine Man Technologies other data
Period | Buy | Sel |
---|---|---|
Aug 2023 | 128155 | 0 |
Sep 2023 | 22152 | 0 |
Dec 2023 | 15158 | 0 |
Apr 2024 | 150 | 0 |
Quarter | Transcript |
---|---|
Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 27 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Justin C. Dye (1973) Executive Chairman & Chief Executive Officer | $311,540 |
Mr. Daniel R. Pabon (1977) Gen. Counsel, Chief Gov. Affairs Officer & Corporation Sec. | $228,460 |
Dr. Nirup N. Krishnamurthy (1962) Director & Chief Operating Officer | $218,310 |
Ms. Nancy Huber (1958) Chief Financial Officer | $207,690 |
Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update
Medicine Man Technologies: Low Sales Multiple Set Against New Mexico, Colorado Expansion
Medicine Man Technologies: Why I Am Buying This Stock
Schwazze: A Tiny Titan And Best Of Breed Operator In The Cannabis Space
Schwazze Executing Well In Difficult Economic Conditions
Schwazze: Signs Of Success For This Unusual Cannabis Company
Medicine Man Technologies, Inc. 2022 Q2 - Results - Earnings Call Presentation
Schwazze: Unexpected Opportunity For Astute Cannabis Investors
Schwazze Remains One Of Top Growth Names Despite Conservative Guide
-
What's the price of Medicine Man Technologies stock today?
One share of Medicine Man Technologies stock can currently be purchased for approximately $0.
-
When is Medicine Man Technologies's next earnings date?
Medicine Man Technologies, Inc. is estimated to report earnings on Monday, 11 Aug 2025.
-
Does Medicine Man Technologies pay dividends?
No, Medicine Man Technologies does not pay dividends.
-
How much money does Medicine Man Technologies make?
Medicine Man Technologies has a market capitalization of 74.42M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.2% to 172.45M US dollars. Medicine Man Technologies made a loss 34.55M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.
-
What is Medicine Man Technologies's stock symbol?
Medicine Man Technologies, Inc. is traded on the OTC under the ticker symbol "SHWZ".
-
What is Medicine Man Technologies's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Medicine Man Technologies?
Shares of Medicine Man Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Medicine Man Technologies's key executives?
Medicine Man Technologies's management team includes the following people:
- Mr. Justin C. Dye Executive Chairman & Chief Executive Officer(age: 52, pay: $311,540)
- Mr. Daniel R. Pabon Gen. Counsel, Chief Gov. Affairs Officer & Corporation Sec.(age: 48, pay: $228,460)
- Dr. Nirup N. Krishnamurthy Director & Chief Operating Officer(age: 63, pay: $218,310)
- Ms. Nancy Huber Chief Financial Officer(age: 67, pay: $207,690)
-
How many employees does Medicine Man Technologies have?
As Jul 2024, Medicine Man Technologies employs 729 workers, which is 12% more then previous quarter.
-
When Medicine Man Technologies went public?
Medicine Man Technologies, Inc. is publicly traded company for more then 9 years since IPO on 25 Jan 2016.
-
What is Medicine Man Technologies's official website?
The official website for Medicine Man Technologies is schwazze.com.
-
Where are Medicine Man Technologies's headquarters?
Medicine Man Technologies is headquartered at 4880 Havana Street, Denver, CO.
-
How can i contact Medicine Man Technologies?
Medicine Man Technologies's mailing address is 4880 Havana Street, Denver, CO and company can be reached via phone at +30 33710387.
Medicine Man Technologies company profile:

Medicine Man Technologies, Inc.
schwazze.comOTC
389
Drug Manufacturers—Specialty & Generic
Healthcare
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
Denver, CO 80239
CIK: 0001622879
ISIN: US58468U1060
CUSIP: 58468U106